295 related articles for article (PubMed ID: 32571254)
1. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
Pu Q; Lv YR; Dong K; Geng WW; Gao HD
BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
[TBL] [Abstract][Full Text] [Related]
3. OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN.
Li J; Yang D; Lin Y; Xu W; Zhao SM; Wang C
Front Pharmacol; 2023; 14():1337732. PubMed ID: 38288086
[No Abstract] [Full Text] [Related]
4. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer.
Zhang P; Li C; Li H; Yuan L; Dai H; Peng Z; Deng Z; Chang Z; Cui CP; Zhang L
Cell Death Differ; 2020 Nov; 27(11):3177-3195. PubMed ID: 32483383
[TBL] [Abstract][Full Text] [Related]
5. An Eimeria acervulina OTU protease exhibits linkage-specific deubiquitinase activity.
Wang P; Gong P; Wang W; Li J; Ai Y; Zhang X
Parasitol Res; 2019 Jan; 118(1):47-55. PubMed ID: 30415394
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
[TBL] [Abstract][Full Text] [Related]
7. Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.
Du T; Gu Q; Zhang Y; Gan Y; Liang R; Yang W; Lu Y; Xu C; Wu J; Ma R; Cao H; Jiang J; Wang J; Feng J
Cell Commun Signal; 2024 Mar; 22(1):195. PubMed ID: 38539203
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.
Du T; Li H; Fan Y; Yuan L; Guo X; Zhu Q; Yao Y; Li X; Liu C; Yu X; Liu Z; Cui CP; Han C; Zhang L
Nat Commun; 2019 Jul; 10(1):2914. PubMed ID: 31266968
[TBL] [Abstract][Full Text] [Related]
9. BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
Mo Q; Xu K; Luo C; Zhang Q; Wang L; Ren G
Biochem Biophys Res Commun; 2021 May; 553():17-24. PubMed ID: 33756341
[TBL] [Abstract][Full Text] [Related]
10. miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.
Geng W; Song H; Zhao Q; Dong K; Pu Q; Gao H; Lv Y
Biomed Res Int; 2020; 2020():9512793. PubMed ID: 32775453
[TBL] [Abstract][Full Text] [Related]
11. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
[TBL] [Abstract][Full Text] [Related]
12. BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.
Zhou Z; Qiu R; Liu W; Yang T; Li G; Huang W; Teng X; Yang Y; Yu H; Yang Y; Wang Y
Cell Prolif; 2021 Aug; 54(8):e13088. PubMed ID: 34240781
[TBL] [Abstract][Full Text] [Related]
13. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53.
Piao S; Pei HZ; Huang B; Baek SH
Cell Signal; 2017 May; 33():22-29. PubMed ID: 28216291
[TBL] [Abstract][Full Text] [Related]
14. GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERĪ± signaling.
Tang HL; Wang Q; Lu JG; Yang XJ; Shi JJ; Wang SP; Cao CQ; Zhao HD
Neoplasma; 2022 Dec; 69(6):1386-1395. PubMed ID: 36591801
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas.
Wang Y; He X; Yu Q; Eng C
Hum Mol Genet; 2013 Jun; 22(11):2263-72. PubMed ID: 23418309
[TBL] [Abstract][Full Text] [Related]
16. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
17. Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity.
Zhang Z; Fang X; Wu X; Ling L; Chu F; Li J; Wang S; Zang J; Zhang B; Ye S; Zhang L; Yang B; Lin S; Huang H; Wang A; Zhou F
Mol Cell; 2020 Jul; 79(2):304-319.e7. PubMed ID: 32679077
[TBL] [Abstract][Full Text] [Related]
18. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase OTUD3: a double-edged sword in immunity and disease.
Xu Q; He L; Zhang S; Di X; Jiang H
Front Cell Dev Biol; 2023; 11():1237530. PubMed ID: 37829187
[TBL] [Abstract][Full Text] [Related]
20. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
